↓ Skip to main content

The Aminopeptidase Inhibitor CHR-2863 Is an Orally Bioavailable Inhibitor of Murine Malaria

Overview of attention for article published in Antimicrobial Agents and Chemotherapy, March 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
37 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Aminopeptidase Inhibitor CHR-2863 Is an Orally Bioavailable Inhibitor of Murine Malaria
Published in
Antimicrobial Agents and Chemotherapy, March 2012
DOI 10.1128/aac.06245-11
Pubmed ID
Authors

Tina S. Skinner-Adams, Christopher L. Peatey, Karen Anderson, Katharine R. Trenholme, David Krige, Christopher L. Brown, Colin Stack, Desire M. M. Nsangou, Rency T. Mathews, Karine Thivierge, John P. Dalton, Donald L. Gardiner

Abstract

Malaria remains a significant risk in many areas of the world, with resistance to the current antimalarial pharmacopeia an ever-increasing problem. The M1 alanine aminopeptidase (PfM1AAP) and M17 leucine aminopeptidase (PfM17LAP) are believed to play a role in the terminal stages of digestion of host hemoglobin and thereby generate a pool of free amino acids that are essential for parasite growth and development. Here, we show that an orally bioavailable aminopeptidase inhibitor, CHR-2863, is efficacious against murine malaria.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 5%
Indonesia 1 3%
Poland 1 3%
Unknown 33 89%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 24%
Student > Ph. D. Student 7 19%
Student > Master 6 16%
Other 4 11%
Student > Bachelor 4 11%
Other 6 16%
Unknown 1 3%
Readers by discipline Count As %
Agricultural and Biological Sciences 13 35%
Biochemistry, Genetics and Molecular Biology 7 19%
Chemistry 4 11%
Medicine and Dentistry 4 11%
Pharmacology, Toxicology and Pharmaceutical Science 3 8%
Other 3 8%
Unknown 3 8%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 September 2012.
All research outputs
#20,655,488
of 25,373,627 outputs
Outputs from Antimicrobial Agents and Chemotherapy
#13,973
of 15,579 outputs
Outputs of similar age
#135,013
of 172,497 outputs
Outputs of similar age from Antimicrobial Agents and Chemotherapy
#105
of 138 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 15,579 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one is in the 5th percentile – i.e., 5% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 172,497 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 138 others from the same source and published within six weeks on either side of this one. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.